WHO Approves Phase 2/3 Trials for Two Ebola Bundibugyo Vaccine Candidates in DRC
Published 3 d ago3 sourcesEvidence: Reported
WHO has recommended two new Ebola vaccines for clinical trials via ring vaccination in the DRC, targeting the Bundibugyo strain. This is a first for this strain, which has historically lacked approved vaccines. The move signals an escalation in response to an active outbreak, though trial efficacy and deployment timelines remain uncertain.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 3 d ago3 sourcesEvidence: Reported
Published 1 d ago4 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 3 d ago3 sourcesEvidence: Reported
Published 3 d ago4 sourcesEvidence: Reported
Published 2 d ago3 sourcesEvidence: Reported